Riverview Capital Advisers’s Stryker SYK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$451K Buy
1,373
+3
+0.2% +$1.08K 0.15% 59
2025
Q4
$482K Sell
1,370
-2,949
-68% -$1.07M 0.15% 63
2025
Q3
$1.6M Hold
4,319
0.46% 46
2025
Q2
$1.71M Sell
4,319
-86
-2% -$32.2K 0.49% 50
2025
Q1
$1.64M Sell
4,405
-15
-0.3% -$5.71K 0.52% 47
2024
Q4
$1.59M Hold
4,420
0.48% 46
2024
Q3
$1.6M Hold
4,420
0.49% 43
2024
Q2
$1.5M Sell
4,420
-25
-0.6% -$8.47K 0.51% 41
2024
Q1
$1.59M Hold
4,445
0.55% 42
2023
Q4
$1.33M Buy
4,445
+20
+0.5% +$5.61K 0.51% 41
2023
Q3
$1.21M Hold
4,425
0.54% 43
2023
Q2
$1.35M Buy
4,425
+4
+0.1% +$1.16K 0.59% 40
2023
Q1
$1.26M Hold
4,421
0.54% 42
2022
Q4
$1.08M Hold
4,421
0.58% 43
2022
Q3
$895K Buy
4,421
+101
+2% +$21.2K 0.56% 47
2022
Q2
$859K Hold
4,320
0.48% 50
2022
Q1
$1.15M Hold
4,320
0.53% 46
2021
Q4
$1.16M Buy
+4,320
New +$1.13M 0.51% 47

Other funds holding SYK

Riverview Capital Advisers's SYK Position: Q1 2026 in Review

Riverview Capital Advisers increased its Stryker (SYK) stake by 0.22% in Q1 2026, buying an estimated $1.08K and bringing the position to 1,373 shares worth $451K. The position accounts for 0.15% of the portfolio, ranked #59.

Riverview Capital Advisers first reported a position in SYK in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.71M in Q2 2025. 2,295 funds tracked by Wall St. Rank hold SYK as of Q1 2026.

  • Riverview Capital Advisers held 1,373 shares of Stryker worth $451K as of Q1 2026.
  • Riverview Capital Advisers bought 3 Stryker shares in Q1 2026, an estimated $1.08K.
  • Stryker made up 0.15% of Riverview Capital Advisers's portfolio in Q1 2026, its #59 holding.
  • Riverview Capital Advisers first reported a position in Stryker in Q4 2021 and has held it in 18 quarters since.
  • Riverview Capital Advisers's Stryker position peaked at $1.71M in Q2 2025.
  • 2,295 funds tracked by Wall St. Rank held Stryker as of Q1 2026.

Based on Riverview Capital Advisers's 13F filing for Q1 2026, filed 14 May 2026.